These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9598656)

  • 41. Urinary incontinence in women.
    Wilkinson E
    Nurs Times; 2006 Nov 28-Dec 4; 102(48):23-4. PubMed ID: 17193773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravesical oxybutynin: practicalities of clinical use.
    Guerrero K; Emery S; Owen L; Rowlands M
    J Obstet Gynaecol; 2006 Feb; 26(2):141-3. PubMed ID: 16483973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma levels of oxybutynine chloride in children.
    Autret E; Jonville AP; Dutertre JP; Bertiere MC; Robert M; Averous M; Couet W
    Eur J Clin Pharmacol; 1994; 46(1):83-5. PubMed ID: 8005192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
    Reitz A; Stöhrer M; Kramer G; Del Popolo G; Chartier-Kastler E; Pannek J; Burgdörfer H; Göcking K; Madersbacher H; Schumacher S; Richter R; von Tobel J; Schurch B
    Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutynin.
    Reiz JL; Salem P; Darke AC
    J Clin Pharmacol; 2007 Mar; 47(3):351-7. PubMed ID: 17322147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
    Serrano Brambila EA; Quiroga Avila RG; Lorenzo Monterrubio JL; Moreno Aranda J
    Ginecol Obstet Mex; 2000 Apr; 68():174-81. PubMed ID: 10824450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of drug-induced dryness of the mouth].
    Durst W
    Ther Ggw; 1978 Jul; 117(7):1102-10. PubMed ID: 675568
    [No Abstract]   [Full Text] [Related]  

  • 48. Which stop test is best? Measuring detrusor contractility in older females.
    Tan TL; Bergmann MA; Griffiths D; Resnick NM
    J Urol; 2003 Mar; 169(3):1023-7. PubMed ID: 12576837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ; Lemack GE; Foote JE; Trop CS
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Urinary incontinence: anticholinergic treatment].
    Jimenez Cidre MA
    Rev Med Univ Navarra; 2004; 48(4):37-42. PubMed ID: 15810718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].
    Noguchi K; Yamagishi T; Suzuki K; Kondo K; Kishida T; Saito K; Sekiguchi Y; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y; Kawai M; Okajima K; Kobayashi K; Moriyama M; Kinoshita Y; Mikata K; Kitami K; Masuda M; Saito R; Murai T; Tomoda T; Noguchi S; Sakai N; Hamano A; Nomura S; Sato K
    Hinyokika Kiyo; 2006 May; 52(5):343-8. PubMed ID: 16758722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The clinical therapic efficiency of anethol trithione on dry eye].
    Wang H; Liu ZG; Peng J; Lin H; Zhong JX; Hu JY
    Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):492-7. PubMed ID: 19957670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudo-obstruction secondary to anticholinergic drugs in Parkinson's disease.
    Howard LM; Markus H
    Postgrad Med J; 1992 Jan; 68(795):70-1. PubMed ID: 1561204
    [No Abstract]   [Full Text] [Related]  

  • 54. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.
    Giannitsas K; Perimenis P; Athanasopoulos A; Gyftopoulos K; Nikiforidis G; Barbalias G
    Eur Urol; 2004 Dec; 46(6):776-82; discussion 782-3. PubMed ID: 15548447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re: Risk of Medication-Associated Initiation of Oxybutynin in Elderly Men and Women.
    Griebling TL
    J Urol; 2015 Aug; 194(2):478. PubMed ID: 26195395
    [No Abstract]   [Full Text] [Related]  

  • 57. Anethole dithiolethione: biochemical considerations.
    Christen MO
    Methods Enzymol; 1995; 252():316-23. PubMed ID: 7476368
    [No Abstract]   [Full Text] [Related]  

  • 58. Urinary continence/incontinence. Nursing implications of drug therapy. Close observation for both expected and unexpected effects is a must.
    Cotterell M; Miller M
    Geriatr Nurs; 1980; 1(4):271-4, 276. PubMed ID: 6903544
    [No Abstract]   [Full Text] [Related]  

  • 59. [Interaction studies using catapresan depot perlongette and a sialogenous drug].
    Langbehn AF; Beurich HW; Kiebbel E; Wolk M
    Med Welt; 1981 Jan; 32(5):171-2. PubMed ID: 7207153
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical experience in the treatment of non-iatrogenic xerostomia and xerophthalmia with trithioparamethoxyphenylpropene].
    Bianucci G; Campana G; Maddali Bongi S; Castagnoli A; Passigli G
    Clin Ter; 1984 Jun; 109(5):417-27. PubMed ID: 6236932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.